410 related articles for article (PubMed ID: 15599396)
1. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.
Boucharaba A; Serre CM; Grès S; Saulnier-Blache JS; Bordet JC; Guglielmi J; Clézardin P; Peyruchaud O
J Clin Invest; 2004 Dec; 114(12):1714-25. PubMed ID: 15599396
[TBL] [Abstract][Full Text] [Related]
2. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.
David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O
PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819
[TBL] [Abstract][Full Text] [Related]
3. Bioactive lipids lysophosphatidic acid and sphingosine 1-phosphate mediate breast cancer cell biological functions through distinct mechanisms.
Boucharaba A; Guillet B; Menaa F; Hneino M; van Wijnen AJ; Clézardin P; Peyruchaud O
Oncol Res; 2009; 18(4):173-84. PubMed ID: 20112503
[TBL] [Abstract][Full Text] [Related]
4. The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.
Boucharaba A; Serre CM; Guglielmi J; Bordet JC; Clézardin P; Peyruchaud O
Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9643-8. PubMed ID: 16769891
[TBL] [Abstract][Full Text] [Related]
5. Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone.
Leblanc R; Lee SC; David M; Bordet JC; Norman DD; Patil R; Miller D; Sahay D; Ribeiro J; Clézardin P; Tigyi GJ; Peyruchaud O
Blood; 2014 Nov; 124(20):3141-50. PubMed ID: 25277122
[TBL] [Abstract][Full Text] [Related]
6. Secretion of IL-6 and IL-8 from lysophosphatidic acid-stimulated oral squamous cell carcinoma promotes osteoclastogenesis and bone resorption.
Hwang YS; Lee SK; Park KK; Chung WY
Oral Oncol; 2012 Jan; 48(1):40-8. PubMed ID: 21925926
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone-related protein and bone metastases.
Guise TA
Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
[TBL] [Abstract][Full Text] [Related]
8. LPA Increases Tumor Growth and Bone Destruction Through Enhancement of Osteoclastogenic Cytokines.
Lindholm PF; Hwang YS
Anticancer Res; 2016 Jan; 36(1):61-70. PubMed ID: 26722028
[TBL] [Abstract][Full Text] [Related]
9. Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis.
Siclari VA; Mohammad KS; Tompkins DR; Davis H; McKenna CR; Peng X; Wessner LL; Niewolna M; Guise TA; Suvannasankha A; Chirgwin JM
Breast Cancer Res; 2014 Dec; 16(6):458. PubMed ID: 25439669
[TBL] [Abstract][Full Text] [Related]
10. Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans.
Kamalakar A; Bendre MS; Washam CL; Fowler TW; Carver A; Dilley JD; Bracey JW; Akel NS; Margulies AG; Skinner RA; Swain FL; Hogue WR; Montgomery CO; Lahiji P; Maher JJ; Leitzel KE; Ali SM; Lipton A; Nicholas RW; Gaddy D; Suva LJ
Bone; 2014 Apr; 61():176-85. PubMed ID: 24486955
[TBL] [Abstract][Full Text] [Related]
11. Platelets and metastasis revisited: a novel fatty link.
Gupta GP; Massagué J
J Clin Invest; 2004 Dec; 114(12):1691-3. PubMed ID: 15599391
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice.
Lev DC; Kim SJ; Onn A; Stone V; Nam DH; Yazici S; Fidler IJ; Price JE
Clin Cancer Res; 2005 Jan; 11(1):306-14. PubMed ID: 15671560
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
Yu S; Murph MM; Lu Y; Liu S; Hall HS; Liu J; Stephens C; Fang X; Mills GB
J Natl Cancer Inst; 2008 Nov; 100(22):1630-42. PubMed ID: 19001604
[TBL] [Abstract][Full Text] [Related]
15. Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption.
Strube A; Hoffmann J; Stepina E; Hauff P; Klar U; Käkönen SM
Clin Cancer Res; 2009 Jun; 15(11):3751-9. PubMed ID: 19470728
[TBL] [Abstract][Full Text] [Related]
16. MAPK11 in breast cancer cells enhances osteoclastogenesis and bone resorption.
He Z; He J; Liu Z; Xu J; Yi SF; Liu H; Yang J
Biochimie; 2014 Nov; 106():24-32. PubMed ID: 25066918
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by interleukin 18 of osteolytic bone metastasis by human breast cancer cells.
Nakata A; Tsujimura T; Sugihara A; Okamura H; Iwasaki T; Shinkai K; Iwata N; Kakishita E; Akedo H; Terada N
Anticancer Res; 1999; 19(5B):4131-8. PubMed ID: 10628364
[TBL] [Abstract][Full Text] [Related]
18. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
[TBL] [Abstract][Full Text] [Related]
19. Human breast-cancer cells stimulate the fusion, migration and resorptive activity of osteoclasts in bone explants.
Tumber A; Morgan HM; Meikle MC; Hill PA
Int J Cancer; 2001 Mar; 91(5):665-72. PubMed ID: 11267975
[TBL] [Abstract][Full Text] [Related]
20. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.
Pivetta E; Scapolan M; Pecolo M; Wassermann B; Abu-Rumeileh I; Balestreri L; Borsatti E; Tripodo C; Colombatti A; Spessotto P
Breast Cancer Res; 2011 Oct; 13(5):R105. PubMed ID: 22032644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
